These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9276623)
1. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623 [TBL] [Abstract][Full Text] [Related]
2. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats. Ho SM; Yu M Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Thompson CJ; Tam NN; Joyce JM; Leav I; Ho SM Endocrinology; 2002 Jun; 143(6):2093-105. PubMed ID: 12021174 [TBL] [Abstract][Full Text] [Related]
4. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats. Ho SM; Yu M J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144 [TBL] [Abstract][Full Text] [Related]
5. Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia. Tam NN; Szeto CY; Freudenberg JM; Fullenkamp AN; Medvedovic M; Ho SM Mol Endocrinol; 2010 Nov; 24(11):2207-17. PubMed ID: 20861223 [TBL] [Abstract][Full Text] [Related]
6. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta. Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268 [TBL] [Abstract][Full Text] [Related]
7. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Ofner P; Bosland MC; Vena RL Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166 [TBL] [Abstract][Full Text] [Related]
9. Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Lau KM; Leav I; Ho SM Endocrinology; 1998 Jan; 139(1):424-7. PubMed ID: 9421443 [TBL] [Abstract][Full Text] [Related]
10. The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Gilleran JP; Putz O; DeJong M; DeJong S; Birch L; Pu Y; Huang L; Prins GS Endocrinology; 2003 May; 144(5):2046-54. PubMed ID: 12697713 [TBL] [Abstract][Full Text] [Related]
11. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709 [TBL] [Abstract][Full Text] [Related]
12. L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats. Özten N; Schlicht M; Diamond AM; Bosland MC Nutr Cancer; 2014; 66(5):825-34. PubMed ID: 24773027 [TBL] [Abstract][Full Text] [Related]
13. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat. Ho SM; Leav I; Ghatak S; Merk F; Jagannathan VS; Mallery K Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473 [TBL] [Abstract][Full Text] [Related]
14. Prolactin (PRL) regulation of maternal behavior in rats: bromocriptine treatment delays and PRL promotes the rapid onset of behavior. Bridges RS; Ronsheim PM Endocrinology; 1990 Feb; 126(2):837-48. PubMed ID: 2298174 [TBL] [Abstract][Full Text] [Related]
15. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats. Ho SM; Roy D Cancer Lett; 1994 Sep; 84(2):155-62. PubMed ID: 8076372 [TBL] [Abstract][Full Text] [Related]
16. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091 [TBL] [Abstract][Full Text] [Related]
17. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats. Lane KE; Ricci MJ; Ho SM Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of estradiol and estrone in organ cultures of dorsolateral and ventral prostate of untreated and sex hormone-implanted rats. Ofner P; Nadeau MR; Vena RL; Leav I Steroids; 1992 Feb; 57(2):50-5. PubMed ID: 1621255 [TBL] [Abstract][Full Text] [Related]
19. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia. Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412 [TBL] [Abstract][Full Text] [Related]
20. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase. Bosland MC; Vega K; Horton L; Schlicht MJ Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]